Seòmar agus comataidhean

Scottish Ministers have not made representation to the UK Government on this issue as the regulation for the licensing, safety and efficacy of medicines is reserved to the UK Government and is the responsibility of the Medicines and Healthcare products Regulatory Agency (MHRA).

Scottish Women's Aid, Victim Support Scotland, Rape Crisis Scotland and COSLA are all members of the Victims Taskforce which has met 4 times since 29 March 2023. The dates and minutes of those meetings can be found at Victims Taskforce - gov.scot. They have also attended meetings of Victim/Survivor Advisory Board which have taken place on 26 July 2023, 20 March 2024 and 13 March 2025.

In addition I meet with key justice stakeholder organisations on a regular basis and as required. The dates of meetings with the 4 requested organisations, along with an overview of topics discussed are as follows:

Scottish Women’s Aid

Temporary Traffic Regulation Orders (TTROs) formed part of the general TRO process review that was carried out in 2021. This review indicated that local authorities were content with the TTRO process already in place.

However, Transport Scotland continues to monitor the feedback from local authorities and other stakeholders to ensure that the system remains responsive and meets the needs of communities and road users.

The Scottish Government reviewed the effectiveness of the Traffic Regulation Order (TRO) process in 2021, engaging with key stakeholders including all local authorities. The review found that, overall, local authorities were satisfied with the system but highlighted areas for improvement, particularly in relation to Experimental Traffic Regulation Orders (ETROs) and Redetermination Orders.

As a result of this assessment, legislative changes were introduced to streamline ETROs, enabling implementation with 7 days’ notice and a 6-month consultation period. Guidance was also issued to clarify that Redetermination Orders may not be required where a TRO sufficiently regulates access.

In addition, Transport Scotland is considering further work to support the digitisation of TROs, with a view to improving accessibility and administrative efficiency.

The information requested is not held centrally. However, data are available that show of the university spin-out companies formed in Scotland less than 5% have registered trading addresses out with Scotland.

Applications for fishing gear, which is the subject of assistance through the Marine Fund Scotland, are considered against the aims of the Fisheries Management Strategy with further input where required from Marine Directorate fishing technology and science leads. Projects are also subject to Post Project Monitoring, where applicants are asked to confirm whether the gear has achieved the intended outcomes such as greater selectivity & sustainability.

In recent years the Scottish Government has invested significantly in manufacturing support infrastructure. The National Manufacturing Institute Scotland (NMIS) represents a £75 million investment by the Scottish Government and its agencies and has a mission to make Scotland a global leader in advanced, sustainable manufacturing. The Advancing Manufacturing Challenge Fund also led to the establishment of a range of facilities across Scotland with either a regional or sectoral focus. These include the Medical Device Manufacturing Centre based at Heriot Watt University, Smart Hub Lanarkshire based at New Lanarkshire College and the Advancing Manufacturing Centre at West Highland College

Meanwhile, we continue to work with the UK Government and local partners on the delivery of tailored regional projects in support of the manufacturing economy. These include the Advanced Manufacturing Innovation District Scotland and Investment Zone projects within the Glasgow City Region and The Manufacturing Innovation Centre for Moray within the Moray Growth Deal. We also anticipate that our Green Freeports package will have a catalytic effect on advanced manufacturing in the two regions affected.

Significant planning work has been undertaken for the Marine Fund Scotland (MFS) for 2025-26 and we hope to be able to confirm arrangements shortly. Potential applicants should provide their details to MFS@gov.scot if they wish to be added to the mailing list.

The national pipeline contains information on a range of investment propositions or projects, all of which are at different stages of development.

The £1.8m Digital Dermatology programme referenced within the NHS Scotland Operational Improvement Plan (OIP) is designed to reduce the number of patients who require a dermatology outpatient appointment through the creation of a digital triage system enabled through image capture within primary care.

The digital dermatology programme is now available in all 14 territorial health boards and is accessible to over 50% of GP practices across NHS Scotland. As referenced in the OIP, we continue to work towards full roll out to all GPs across Scotland by the end of Spring 2025.

For patients, evidence suggests that this will allow around 50% to be returned to the GP with advice or reassurance, without having an in-person appointment with a consultant. Some patients are also likely to be fast-tracked to further diagnostics or treatment based on assessment at this digital triage stage.

The Scottish Government commissioned National Elective Coordination Unit’s (NECU) work is complementing the national Digital Dermatology programme by focusing on high-volume patient validation within an accelerated timeline, as well as developing robust digital infrastructure for image capture and clinical triage, and ensuring a well-structured workforce model for governance and clinical safety.

The Scottish Government has worked with NECU to establish comprehensive governance arrangements and a workforce framework that promotes collaborative efforts across NHS Boards. This has enabled the onboarding of 18 dermatology consultants and the creation of digital infrastructure to support clinical workflows.

NECU’s dermatology campaign has already engaged four Health Boards – including NHS Greater Glasgow & Clyde, NHS Grampian, NHS Ayrshire & Arran and NHS Highland - addressing the needs of patients waiting over 52 weeks and ensuring patient requirements are correctly recorded. As we progress, our goal is to continue leveraging these innovations to improve patient outcomes and streamline dermatological care delivery.